SuperworthPacira BioSciences shares outstanding PCRX
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 40.3M
- On a year earlier
- −11.3%
- fewer shares
Pacira BioSciences had 40.3M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 11.3% fewer than a year earlier, so each share owns a little more of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 43M | −7% |
| FY2024 | 46.2M | −33% |
| FY2023 | 68.7M | +50% |
| FY2022 | 45.9M | +3% |
| FY2021 | 44.6M | −0% |
| FY2020 | 44.7M | +7% |
| FY2019 | 41.8M | +2% |
| FY2018 | 41.1M | +1% |
| FY2017 | 40.6M | +8% |
| FY2016 | 37.4M | +2% |
| FY2015 | 36.8M | +4% |
| FY2014 | 35.3M | +5% |
| FY2013 | 33.6M | +3% |
| FY2012 | 32.6M | +53% |
| FY2011 | 21.2M | +3597% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 40.3M | −11% | |
| Q1 FY26 | 40.9M | −12% | |
| Q4 FY25 | 43M | −7% | |
| Q3 FY25 | 44.5M | −4% | |
| Q2 FY25 | 45.5M | −10% | |
| Q1 FY25 | 46.5M | −11% | |
| Q4 FY24 | 46.2M | −33% | |
| Q3 FY24 | 46.1M | −11% | |
| Q2 FY24 | 50.5M | −3% | |
| Q1 FY24 | 52.2M | +14% | |
| Q4 FY23 | 68.7M | +50% | |
| Q3 FY23 | 52.1M | +14% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Pacira BioSciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.